已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Etanercept does not effectively treat moderate to severe alopecia areata: An open-label study

打开标签 不利影响 内科学 银屑病
作者
Bruce Strober,Kimberly Siu,Andrew Alexis,Gene Kim,Ken Washenik,Animesh A. Sinha,Jerome L. Shupack
出处
期刊:Journal of The American Academy of Dermatology [Elsevier BV]
卷期号:52 (6): 1082-1084 被引量:120
标识
DOI:10.1016/j.jaad.2005.03.039
摘要

In this prospective, open-label pilot study, we evaluated the safety and efficacy of etanercept, a TNF-α inhibitor, in the treatment of moderate to severe alopecia areata, alopecia totalis, or alopecia universalis. Seventeen otherwise healthy adults with moderate to severe alopecia areata were enrolled. The primary outcome measure was the extent of hair regrowth during and after the end of treatment as evaluated by the Severity of Alopecia Tool (the SALT score). After between 8 and 24 weeks of continuous treatment with etanercept 50 mg given subcutaneously twice weekly, significant regrowth of hair was not shown in any of the subjects treated. Based on these results, etanercept appears to be ineffective in treating subjects with treatment-refractory, moderate to severe alopecia areata, alopecia totalis, or alopecia universalis. In this prospective, open-label pilot study, we evaluated the safety and efficacy of etanercept, a TNF-α inhibitor, in the treatment of moderate to severe alopecia areata, alopecia totalis, or alopecia universalis. Seventeen otherwise healthy adults with moderate to severe alopecia areata were enrolled. The primary outcome measure was the extent of hair regrowth during and after the end of treatment as evaluated by the Severity of Alopecia Tool (the SALT score). After between 8 and 24 weeks of continuous treatment with etanercept 50 mg given subcutaneously twice weekly, significant regrowth of hair was not shown in any of the subjects treated. Based on these results, etanercept appears to be ineffective in treating subjects with treatment-refractory, moderate to severe alopecia areata, alopecia totalis, or alopecia universalis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
终须有完成签到 ,获得积分10
1秒前
T0Yu发布了新的文献求助10
2秒前
丘比特的应助被博修采纳,获得10
2秒前
深情安青的应助被yang采纳,获得10
4秒前
爆米花的应助被yang采纳,获得10
4秒前
大个的应助被yang采纳,获得10
4秒前
JamesPei的应助被yang采纳,获得10
4秒前
SciGPT的应助被yang采纳,获得10
4秒前
科研通AI2S的应助被yang采纳,获得10
4秒前
情怀的应助被yang采纳,获得10
5秒前
Orange的应助被yang采纳,获得10
5秒前
搜集达人的应助被yang采纳,获得10
5秒前
充电宝的应助被yang采纳,获得10
5秒前
8秒前
8秒前
彭于晏的应助被xxdwyd采纳,获得10
10秒前
我吃吃吃吃吃吃完成签到 ,获得积分10
10秒前
11秒前
11秒前
daomaihu发布了新的文献求助100
12秒前
mycoplasma完成签到 ,获得积分10
12秒前
万万发布了新的文献求助10
13秒前
jmc发布了新的文献求助10
13秒前
林深完成签到 ,获得积分10
15秒前
yuanyu发布了新的文献求助10
15秒前
雪山大地发布了新的文献求助10
16秒前
陈预立发布了新的文献求助10
17秒前
思源的应助被鳗鱼雪莲采纳,获得10
18秒前
杏仁和巧克力完成签到 ,获得积分10
18秒前
21秒前
21秒前
SciGPT的应助被温某人采纳,获得10
21秒前
由道罡完成签到 ,获得积分10
22秒前
24秒前
乐乐的应助被橙橙采纳,获得10
25秒前
RRGrel完成签到,获得积分10
26秒前
数据线完成签到 ,获得积分10
27秒前
LIXIA完成签到 ,获得积分10
27秒前
27秒前
认真青曼完成签到,获得积分20
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172605
求助须知:如何正确求助?哪些是违规求助? 9565323
关于积分的说明 21778953
捐赠科研通 7764352
什么是DOI,文献DOI怎么找? 3431411
关于科研通互助平台的介绍 2555301
邀请新用户注册赠送积分活动 2476394